Loading provider…
Loading provider…
Gynecologic Oncology Physician in Springfield, IL
NPI: 1346278041Primary Practice Location
MEMORIAL MEDICAL CENTER
701 N 1st St, Springfield, IL
Primary Employer
SIU Healthcare
siumed.org
HQ Phone
Get MD, PHD Laurent's Phone Numberphone_androidMobile
Get MD, PHD Laurent's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
2011 - 2026
RI State Medical License
2002 - 2020
MA State Medical License
2003 - 2018
CT State Medical License
2006 - 2017

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
Women and Infants Hospital of Rhode Island/Brown University
Fellowship • Gynecologic Oncology
2002 - 2005
Residency • Obstetrics and Gynecology
1998 - 2002
University of Pittsburgh School of Medicine
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 84 | 193 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 49 | 49 |
| 3 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 16 | 16 |
| 4 | 38570Removal of abdominal cavity lymph nodes using an endoscope | 16 | 16 |
| 5 | 38900Lymph node imaging during surgery | 15 | 15 |
Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women & Infants' Hospital.
Authors: Christina Bandera
Publication Date: 2006-06
Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
Authors: Vijayalakshmi Ayyagari, Laurent Brard
Publication Date: 2013-10-01
Lead Sponsor: Women and Infants Hospital of Rhode Island
Intervention / Treatment: DIAGNOSTIC_TEST: Biomarker LPA and HE4
Lead Sponsor: Southern Illinois University
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Capecitabine, DRUG: Gemcitabine Hydrochloride, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Chemotherapy, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, DRUG: Erlotinib Hydrochloride, RADIATION: 3-Dimensional Conformal Radiation Therapy